Andy Pasternak, Director of Context Therapeutics CNTX, has filed 0 purchases and 1 sale on the open market. The latest trade was on 06/24.

AP

AP

Andy Pasternak

Director

Company

Context Therapeutics CNTX

First filing

23/01/04

Trades

29 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

06/24

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
HP Horizon Therapeutics Public	Open-market sale	23/01/17	23/01/18	27,129 sh	$113.03	$3,066,390.87	−32.5%